【レポートの概要（一部）】
Table of Content
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Gout Therapeutics Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Introduction of urate-lowering agents
3.1.1.2 Rising prevalence of gout
3.1.2 Market restraint analysis
3.1.2.1 Competition from generic drugs
3.1.2.2 High cost of recently launched drugs
3.2 Penetration & Growth Prospects Mapping
3.3 Gout Therapeutics Market – PESTLE Analysis
3.4 Industry Analysis – Porter’s
3.5 Gout Therapeutics Competitive Scenario
3.5.1 Competitive landscape: Market position analysis (based on product portfolio, regional presence and strategic initiatives)
Chapter 4 Gout Therapeutics: Drug Class Estimates & Trend Analysis
4.1 Global Gout Therapeutics Market: Drug Class Movement Analysis
4.2 NSAIDs
4.2.1 NSAIDs market estimates and forecasts, 2014 – 2025 (USD Million)
4.3 Corticosteroids
4.3.1 Corticosteroids market estimates and forecasts, 2014 – 2025 (USD Million)
4.4 Colchicine
4.4.1 Colchicine market estimates and forecasts, 2014 – 2025 (USD Million)
4.5 Urate-Lowering Agents
4.5.1 Urate-lowering agents market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 5 Gout Therapeutics: Disease Condition Estimates & Trend Analysis
5.1 Global Gout Therapeutics Market: Disease Condition Movement Analysis
5.2 Acute Gout
5.2.1 Acute market estimates and forecasts, 2014 – 2025 (USD Million)
5.3 Chronic Gout
5.3.1 Chronic gout market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 6 Gout Therapeutics: Regional Estimates & Trend Analysis
6.1 Regional Movement Analysis & Market Share, 2015 & 2025
6.2 North America
6.2.1 North America gout therapeutics market, by drug class, 2014 – 2025 (USD Million)
6.2.2 North America gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. gout therapeutics market, by drug class, 2014 – 2025 (USD Million)
6.2.3.2 U.S. gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.2.4 Canada
6.2.4.1 Canada gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.2.4.2 Canadagout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.3 Europe
6.3.1 Europe gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.3.2 Europe gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Germany gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.3.3.2 Germanygout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.3.4 UK
6.3.4.1 UK gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.3.4.2 UK gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.4.2 Asia Pacific gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.4.3 Japan
6.4.3.1 Japan gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.4.3.2 Japan gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.4.5 China
6.4.5.1 China gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.4.5.2 China gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.5.2 Latin America gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.5.3.2 Brazilgout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexicogout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.5.4.2 Mexicogout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.6 MEA
6.6.1 MEA gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.6.2 MEA gout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa gout therapeuticsmarket, by drug class, 2014 – 2025 (USD Million)
6.6.3.2 South Africagout therapeuticsmarket, by disease condition , 2014 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Takeda Pharmaceutical Company Ltd.
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 Novartis
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 Savient Pharmaceuticals
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Regeneron Pharmaceuticals
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 AstraZeneca plc
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Horizon Pharma plc
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic Initiatives
7.7 Boehringer Ingelheim
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 Merck & Co. Inc
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 Teijin Pharma Ltd
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 GlaxoSmithKline plc
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives
【レポート販売概要】
■ タイトル：痛風治療薬の世界市場分析：薬の種類別（非ステロイド性抗炎症薬[NSAIDs]、コルチコステロイド、コルヒチン、尿酸塩低下薬）、病気の状態別（急性痛風、慢性痛風）、セグメント予測、2014-2025■ 英文：Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory Drugs [NSAIDs], Corticosteroids, Colchicine, Urate-Lowering Agents), By Disease Condition (Acute Gout, Chronic Gout), And Segment Forecasts, 2014-2025
■ 発行日：2017年3月7日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707374
■ 調査対象地域：グローバル
- 世界のポリマー・フォーム市場：ポリウレタン、ポリスチレン、ポリ塩化ビニル、ポリオレフィン、フェノール樹脂、メラミンなどPolymer foam market is dominated by Asia-Pacific region securing more than one third of global market share. China was leading the demand for polymer foam in Asia-Pacific region, growing with the highest CAGR. Europe and North America were following the Asia-Pacific polymer foam market and were home to the largest players of industry such as BASF SE (Germany) and INEOS Styrenics (Switzerland). Bui …
- 中東・アフリカ（MENA）の継目無銅管市場2015-2019About Seamless Copper Tubes The seamless copper tubes market in MENA is highly dependent on imports from suppliers in China, the Far East (Malaysia, Thailand, and Japan), the US, and Europe as there are no major local suppliers apart from Iran. Qaem Copper in Iran is a major supplier of seamless copper tubes in the region, mainly catering to the local demand in Iran and exporting in smaller quanti …
- 世界における頭蓋顎顔面固定（CMF）デバイスの製品パイプライン動向2015Cranio Maxillofacial Fixation (CMF) - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Cranio Maxillofacial Fixation (CMF) - Pipeline Review, 2015" provides an overview of Cranio Maxillofacial Fixation currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of developme …
- 業務用食品サービスの米国市場ABSTRACTAbout Commercial Foodservices Equipment Commercial foodservice equipment help end-users to prepare, cook, serve, and handle various food and beverage items in commercial kitchens. The growth of this market in the US is driven by the growth of the foodservice market coupled with the strategic alliance between vendors. For instance, in November 2015, Blendtec entered into a partnership with …
- Saras S.p.A.：石油・ガスバリューチェーン分析レポート2013Saras S.p.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Saras S.p.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Saras S.p.A.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s busin …
- Dilated Cardiomyopathy：グローバル臨床試験レビューH2, 2013Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2013" provides data on the Dilated Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dilated Cardiomyopathy. It includes an overview of the trial numbers and …
- 不安障害とうつ病治療の世界市場分析：製品別（抗うつ薬、SSRI、SNRI、ベンゾジアゼピン、装置と治療、TNS、DBS、VBS）、症状別（MDD、OCD、恐怖症）、セグメント予測、2014-2025The global anxiety disorders and depression treatment market is expected to reach a value of USD 18.3 billion by 2025. The rising incidence of depression worldwide is anticipated to drive the market growth in the coming years. Increasing adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in the recent years. The rising geriatric population prone to dep …
- ヘキサフルオロジルコニウム酸の世界市場Hexafluorozirconic Acid (CAS 12021-95-3) World Market Report 2013 presents comprehensive data on hexafluorozirconic acid markets globally and regionally (Europe, Asia, North America etc.) The Hexafluorozirconic Acid (CAS 12021-95-3) World Market Report 2013 includes hexafluorozirconic acid description, covers its application areas and related patterns. It overviews hexafluorozirconic acid market, …
- 防衛ビジネス・コンフィデンス・レポート（2013.4Q）Why was the report written? This report is the result of an extensive survey drawn from Strategic Defence Intelligence’s exclusive panel of leading global defense industry executives. The report analyzes current economic conditions prevailing across the globe and their impact on the defense industry, and forecasts the companies’ and industry’s growth prospects over the next six months. Furthermore …
- イランの発電市場2016：市場動向、制度、競争状況Iran Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations and Competitive Landscape Summary This report elaborates Iran's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Iran power market’s regulatory structure, import and export trends, competitive landscape, and power projects at v …
- 世界のチタン市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of titanium, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing titanium production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: titanium prod …
- Amitifadine (大うつ病性障害)：医薬品市場予測及び分析（～2023）Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries …
- 2014年戦略提言：スペインの病院内感染症検査市場This new report from Venture Planning Group contains 880 pages, 73 tables, and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.&nbs …
- 拡張現実（AR）及び仮想現実（VR）市場におけるM&A、未公開株式投資、特許申請分析Augmented reality (AR) is a technology that overlays a computer-generated image on a user’s view which connects the real world with the virtual world. This technology enhances the perception of reality, thereby increasing the user experience and also provides data about the consumer’s immediate environment. The virtual reality (VR) technology provides the user a virtual environment with the help o …
- 軍用UGV（無人地上車両）の世界市場2015-2025The latest report from business intelligence provider visiongain offers comprehensive analysis of the global military unmanned ground vehicle (UGV) market. Visiongain assesses that this market will generate revenues of $412.5m in 2015. How this report will benefit you Read on to discover how you can exploit the emerging business opportunities within the UGV sector before your competitors. In this …
